Training in Drug Abuse & HIV Prevention for Female & Transgender Sex Workers

药物滥用培训

基本信息

  • 批准号:
    8882385
  • 负责人:
  • 金额:
    $ 16.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Malaysia's HIV epidemic, historically driven by male people who inject drugs (PWIDs), has transitioned over the last two decades to a generalized epidemic with bridges between substance abuse and sexual transmission. During this period, females have accounted for a growing proportion of new HIV infections (from 1% in 1990 to 25% in 2011), which are overwhelmingly attributed to sexual transmission. Transgender women have also faced a growing HIV burden in the region, with recent evidence suggesting they are one of the highest at-risk subpopulations globally. Sex work and the frequent co-occurrence of substance abuse is a major risk factor for both females and transgender women, especially in Malaysia, which has become a major destination for sex tourism. Despite recommendations by international agencies (WHO, UNODC, UNAIDS) to implement innovative, combination approaches to HIV and substance abuse prevention, especially among women, uptake in Malaysia, and Southeast Asia generally, has been woefully inadequate. Novel approaches to addressing the complex syndemic of sex work and substance abuse among female and transgender sex workers (F/TGSWs) are in demand. The mentored projects proposed here address this need through the conduct of two formative research studies. The first will estimate the prevalence of HIV and STIs among F/TGSWs in Malaysia's Klang Valley, assess sexual and drug risk behaviors, and determine feasibility of behavioral and biomedical approaches to HIV and substance use prevention. The second study will build on the first by adapting behavioral and biomedical interventions to address co-occurring sexual and drug risk behaviors among F/TGSWs in the region. Findings from these projects will contribute to a greater understanding of HIV and substance abuse risk behaviors among the target population and establish the knowledge necessary to develop innovative approaches to addressing them. The candidate, Dr. Wickersham, is uniquely poised to perform this work because of his strong background in gender and women's studies, his research productivity in the area of public health, and his experience with research in the Malaysian context. Over the five years of this proposal, he will achieve his career goals and professional objectives to: 1) develop expertise in research methods necessary to design, perform, and adapt HIV risk reduction interventions and eventually conduct clinical trials relating to HIV and STI prevention among TGW and FSWs in Malaysia; 2) gain experience in intervention development, adaptation, testing, implementation, and dissemination that will address gender-specific barriers to HIV prevention and treatment services; and 3) develop an independent career path in patient-oriented research focused on the interface between HIV, women's health, gender, and substance abuse and prevention. To achieve these goals, Dr. Wickersham has assembled a team of outstanding leaders in the fields of HIV, substance abuse, epidemiology, and behavioral and biomedical intervention science. Under their guidance, he will complete relevant coursework, attend seminars, and conduct research to apply the skills necessary to become an independent investigator in HIV and substance abuse prevention among female and transgender women sex workers in the Malaysian context.
描述(由申请人提供):马来西亚的艾滋病毒流行病,历史上是由注射毒品(PWID)的男性驱动的,在过去的二十年中,已转变为普遍的流行病,并在药物滥用和性传播之间桥梁。在此期间,女性占了新的HIV感染的比例越来越多(从1990年的1%到2011年的25%),这绝对归因于性传播。跨性别妇女在该地区也面临着越来越多的艾滋病毒负担,最近的证据表明,在全球处于危险中,他们是最高风险的亚种群之一。性工作和频繁的药物滥用同时发生是女性和跨性别妇女的主要危险因素,尤其是在马来西亚,这已成为性旅游的主要目的地。尽管国际机构(谁,纽约市企业,联合国署)建议实施创新的,但对预防艾滋病毒和药物滥用的结合方法,尤其是在妇女中,马来西亚的吸收,东南亚的吸收,通常是不足的。需求解决女性和变性性工作者(F/TGSW)中性工作和滥用药物滥用的复杂综合性的新方法。这里提出的指导项目通过进行两项形成性研究来满足这一需求。第一个将估计马来西亚克兰谷的F/TGSW中艾滋病毒和性传播感染的患病率,评估性和毒品风险行为,并确定艾滋病毒和预防药物使用的行为和生物医学方法的可行性。第二项研究将在第一个研究基础上通过调整行为和生物医学干预措施来解决该地区的F/TGSW中共同发生的性和药物风险行为。这些项目的发现将有助于对目标人群中的艾滋病毒和滥用毒品滥用风险行为有所帮助,并建立开发创新方法来解决这些艾滋病毒的知识。候选人威克瑟姆(Wickersham)博士独特地准备执行这项工作,因为他在性别和妇女研究方面具有强大的背景,他在公共卫生领域的研究生产力以及他在马来西亚背景下的研究经验。在这项提案的五年中,他将实现自己的职业目标和专业目标:1)在设计,执行和适应降低HIV风险的研究方法方面发展专业知识,并最终在马来西亚的TGW和TGW和FSW中进行与HIV和STI预防有关的临床试验; 2)在干预开发,适应,测试,实施和传播方面获得经验,这些经验将解决针对艾滋病毒预防和治疗服务的性别特定障碍; 3)在以患者为导向的研究中发展独立的职业道路,该研究重点是艾滋病毒,妇女健康,性别,滥用药物和预防之间的界面。为了实现这些目标,威克瑟姆博士召集了一支在艾滋病毒,滥用药物,流行病学以及行为和生物医学干预科学领域的杰出领导人团队。在他们的指导下,他将完成相关的课程,参加研讨会并进行研究,以运用在马来西亚的女性和跨性别女性性工作者中成为艾滋病毒和滥用毒品滥用的独立调查员所必需的技能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeffrey Allen Wickersham其他文献

Jeffrey Allen Wickersham的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeffrey Allen Wickersham', 18)}}的其他基金

Strengthening the HIV care continuum for transgender women living with HIV in Malaysia
加强马来西亚感染艾滋病毒的跨性别女性的艾滋病毒护理连续性
  • 批准号:
    10650426
  • 财政年份:
    2022
  • 资助金额:
    $ 16.76万
  • 项目类别:
Gamification to enhance engagement in HIV prevention and co-morbid conditions in young men who have sex with men
游戏化可提高男男性行为年轻男性对艾滋病毒预防和共病的参与度
  • 批准号:
    10620338
  • 财政年份:
    2022
  • 资助金额:
    $ 16.76万
  • 项目类别:
Strengthening the HIV care continuum for transgender women living with HIV in Malaysia
加强马来西亚感染艾滋病毒的跨性别女性的艾滋病毒护理连续性
  • 批准号:
    10484525
  • 财政年份:
    2022
  • 资助金额:
    $ 16.76万
  • 项目类别:
Gamification to enhance engagement in HIV prevention and co-morbid conditions in young men who have sex with men
游戏化可提高男男性行为年轻男性对艾滋病毒预防和共病的参与度
  • 批准号:
    10484651
  • 财政年份:
    2022
  • 资助金额:
    $ 16.76万
  • 项目类别:
Developing an Artificial Intelligence Chatbot to Promote HIV Testing
开发人工智能聊天机器人以促进艾滋病毒检测
  • 批准号:
    10194372
  • 财政年份:
    2020
  • 资助金额:
    $ 16.76万
  • 项目类别:
Developing an Artificial Intelligence Chatbot to Promote HIV Testing
开发人工智能聊天机器人以促进艾滋病毒检测
  • 批准号:
    10082768
  • 财政年份:
    2020
  • 资助金额:
    $ 16.76万
  • 项目类别:
Training in Drug Abuse & HIV Prevention for Female & Transgender Sex Workers
药物滥用培训
  • 批准号:
    8790248
  • 财政年份:
    2014
  • 资助金额:
    $ 16.76万
  • 项目类别:

相似国自然基金

签字注册会计师动态配置问题研究:基于临阵换师视角
  • 批准号:
    72362023
  • 批准年份:
    2023
  • 资助金额:
    28 万元
  • 项目类别:
    地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
  • 批准号:
    72372064
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
  • 批准号:
    72372028
  • 批准年份:
    2023
  • 资助金额:
    42.00 万元
  • 项目类别:
    面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
  • 批准号:
    72362001
  • 批准年份:
    2023
  • 资助金额:
    28.00 万元
  • 项目类别:
    地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
  • 批准号:
    72332002
  • 批准年份:
    2023
  • 资助金额:
    165.00 万元
  • 项目类别:
    重点项目

相似海外基金

RP3 PrEP Choice
RP3 PrEP 选择
  • 批准号:
    10595903
  • 财政年份:
    2023
  • 资助金额:
    $ 16.76万
  • 项目类别:
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
  • 批准号:
    10762645
  • 财政年份:
    2023
  • 资助金额:
    $ 16.76万
  • 项目类别:
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department
智能屏幕:利用数字健康改善急诊科青少年的艾滋病毒筛查和预防
  • 批准号:
    10711679
  • 财政年份:
    2023
  • 资助金额:
    $ 16.76万
  • 项目类别:
RP1 Screen 2 Prevent
RP1 屏蔽 2 预防
  • 批准号:
    10595901
  • 财政年份:
    2023
  • 资助金额:
    $ 16.76万
  • 项目类别:
Assessing the use of MY-RIDE, a just-in-time adaptive intervention, to Improve HIV prevention and Substance Use in Youth Experiencing Homelessness
评估 MY-RIDE(一种及时适应性干预措施)的使用情况,以改善无家可归青少年的艾滋病毒预防和药物使用
  • 批准号:
    10836097
  • 财政年份:
    2023
  • 资助金额:
    $ 16.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了